Cardiology

ESC Congress 2025: Innovations, AI, and Patient-Centric Care in Cardiology

At this year’s European Society of Cardiology (ESC) Congress in Madrid, one of the world’s largest medical conferences, I was privileged to see how cardiology is evolving and how AI in cardiology and digital health are not just buzzwords but real drivers toward more equitable, effective, and patient-centric care. The sessions offered hope, especially for…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
ISMPP

21st Annual Meeting of ISMPP: A Summarized Report

The 21st Annual Meeting of ISMPP was held from May 12-14, 2025, in Washington, D.C...
Caregivers, Clinical Trials, Global Pharma, Health Outcomes, Patient Advocacy, Patient Centricity, patient communication, Patient Engagement, Patient Inclusion, Patient Participation

Improving Health Outcomes by Empowering Patients: The Future Is Here

Empowering patients and involving them as key stakeholders in the drug development lifecycle can help...

Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward

Ensuring that your organization embraces DE & I training is important for cultivating a strong...
HEOR Pharma Payers

Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements

HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
man reviewing clinical data, current treatments, economic data, product information, and data on burden of disease

HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats

Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...

Learn more ABOUT our company.